The full text of Choosing Wisely’s email reply to patients: “Thank you for raising your concerns and sharing your personal experience. Choosing Wisely Canada and our partners, the Canadian Society of Endocrinology and Metabolism (CSEM) are not recommending to eliminate T3 testing. Choosing Wisely Canada is a national, clinician-led campaign focused on reducing unnecessary tests and treatments that offer no clinical value to patients and can cause harm. The recommendation in question, like all of our recommendations, encourages patients and physicians to have thoughtful conversations about their care which are informed by scientific evidence. Whether something is necessary or not …
Category: Health care system
Choose Evidence. Choose Free T3.
What are thyroid patients asking for? True evidence-based medicine. T3 is the most powerful thyroid hormone. Don’t assume thyroid patients have optimal T3 whenever their TSH and T4 are normal. Choose wisely. Test Free T3. PETITION LINK: https://petitions.ourcommons.ca/en/Home/Index Read our Campaign Statement for more information
Canadian Thyroid Patients’ Federal Petition
View & Sign our petition Between August 27 and December 25, 2018, we are collecting e-signatures on the Government of Canada’s official website for petitions. Our petition is called “E-1819 (Hypothyroidism)” and is available at this link: https://petitions.ourcommons.ca/en/Petition/Details?Petition=e-1819 The petition system requires a valid email address for verification and will not include your signature until you click the link you receive via email. Apparently some functions do not work via Firefox browsers. Names are kept anonymous to the public. The bottom of the petition page shows the current number of signatures and gives numbers by province. Canadian residents living abroad …
REVIEW: Dr. Antonio Bianco’s 2016 interview on hypothyroidism
In 2016, Dr. Elizabeth McAninch and Dr. Antonio Bianco published a research paper called “The History and Future of Treatment with Hypothyroidism.” On Dr. Bianco’s research team’s website, deiodinase.org, there is a blog post about this study that includes a wonderful video of Dr. McAninch talking about the historical research they did on thyroid therapy. Below that video, you will also find an audio file that you can listen to, a 16-minute interview between The People’s Pharmacy and Dr. Antonio Bianco, discussing the percentage of patients who do not fare well on Levothyroxine (L-T4) monotherapy, and the research on combination …
Why T4 monotherapy has dominated
All thyroid hormone medications have the potential to be effective: L-T4 (Levothyroxine), L-T3 (Liothyronine), and natural desiccated thyroid (DTE / NDT). However, each patient is unique in their response to these medications. Optimizing a patient’s lifelong therapy involves finding the right thyroid hormone medication, or a combination of them, to relieve as many symptoms of hypothyroidism as possible without causing symptoms of hyperthyroidism. Most patients are offered only one therapy, L-T4 monotherapy (Synthroid, Levothyroxine, Eltroxin, Euthyrox). This therapy is apparently effective for many patients. However, a significant minority of patients on L-T4 therapy do not achieve relief of hypothyroid symptoms. …